Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.

Ji Hyun LeeJae Hui KimJong Woo KimChul Gu KimDong Won Lee

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

The high frequency of hospital visits and that of anti-VEGF injections in patients with type 3 neovascularization suggests high treatment burden in these patients. The high incidence of bilateral involvement could be one of the primary reasons for high treatment burden in patients with type 3 neovascularization.

Keyphrases

high frequency
age related macular degeneration
vascular endothelial growth factor
risk factors
healthcare
end stage renal disease
chronic kidney disease
diabetic retinopathy
newly diagnosed
transcranial magnetic stimulation
ejection fraction
emergency department
endothelial cells
adverse drug